Trademark: 98731337
Word
COSUNTER
Status
Pending
Status Code
630
Status Date
Tuesday, September 3, 2024
Serial Number
98731337
Mark Type
4
Filing Date
Tuesday, September 3, 2024

Trademark Owner History

Classifications
5 Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicines for human purposes, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Drugs for medical purposes, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Pharmaceutical preparations, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Crude drugs, namely, medicines, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Biochemical medicines, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes.

Trademark Events
Sep 3, 2024
New Application Entered
Sep 3, 2024
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24